Dr. Douglas F. Nixon

• 
  www.prn.org/index.php/prn_news/news/united_states_resea - [Cached Version]
  Published on: 11/9/2007    Last Visited: 1/8/2008  

  However, team member Dr. Douglas Nixon, an immunologist at UCSF, warned that much research must be done before a vaccine based on HERVs could be ready for testing.

• 
  www.sciencedaily.com/releases/2007/11/071109091107.htm - [Cached Version]
  Published on: 1/1/2007    Last Visited: 11/11/2007  

  "These findings may lead to new lines of attack against HIV, and the clue came from the study of the viruses within us," said study co-senior author, Douglas F. Nixon, MD, PhD, professor of medicine in the UCSF Division of Experimental Medicine.

• 
  www.aidsinfonyc.org/tag/tx/stis.html - [Cached Version]
  Published on: 7/1/1999    Last Visited: 3/10/2007  

  Doug NixonAaron Diamond AIDS Research Center

• 
  pharmiran.com/newsdes.asp?id=1780 - [Cached Version]
  Published on: 11/11/2007    Last Visited: 11/16/2007  

  "These findings may lead to new lines of attack against HIV, and the clue came from the study of the viruses within us," said study co-senior author, Douglas F. Nixon, MD, PhD, professor of medicine in the UCSF Division of Experimental Medicine.

• 
  EGPAF: Grants and Awards - [Cached Version]
  Published on: 4/13/2006    Last Visited: 7/24/2008  

  2000 - Douglas F. Nixon, M.B., B.S., D.Phil.The J. David Gladstone InstitutesSan Francisco, California
  
  Dr. Nixon is working to understand how antiviral white blood cells function in pediatric HIV infection, why they malfunction, and how these responses may be augmented or improved.

• 
  Elizabeth Glaser Scientist Awards - [Cached Version]
  Published on: 1/17/2002    Last Visited: 4/17/2003  

  Douglas F. Nixon, M.B., B.S., D.Phil.Aaron Diamond AIDS Research Center
  ...
  Dr. Nixon is working to understand how antiviral white blood cells function in pediatric HIV infection, why they malfunction, and how these responses may be augmented or improved.

• 
  HIV+ Issue 12: A Quick Fix - [Cached Version]
  Published on: 12/1/2001    Last Visited: 7/14/2008  

  Douglas Nixon of the Aaron Diamond AIDS Research Center has been studying people who interrupt treatment the way Wilson does.
  ...
  Nixon is deeply troubled by the "drug holiday" type of haphazard starting and stopping occurring among many HIV-positive individuals."It's not safe to stop and start on your own," he says.

• 
  HealthScout-Sex and Relationships-Researchers Flip... - [Cached Version]
  Published on: 10/12/2004    Last Visited: 10/12/2004  

  "This is one of the first studies to show that it may be possible in the future to manipulate the natural immune system to make it work better," says Dr. Douglas Nixon, an associate professor of medicine at the University of California at San Francisco.
  ...
  SOURCES: Douglas Nixon, M.D., Ph.D., associate professor, medicine, University of California, San Francisco; Kim J. Hasenkrug, Ph.D., researcher, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Mont.; March 2004 Immunity

• 
  Meriter Health Services – News - [Cached Version]
  Published on: 2/6/2004    Last Visited: 12/12/2004  

  "This is one of the first studies to show that it may be possible in the future to manipulate the natural immune system to make it work better," says Dr. Douglas Nixon, an associate professor of medicine at the University of California at San Francisco.
  
  Over the past decade, drugs known as antiretrovirals have revolutionized the treatment of viruses such as AIDS and hepatitis.

• 
  Out of Control, AIDS and the Corruption of Medical... - [Cached Version]
  Published on: 6/26/2005    Last Visited: 1/10/2007  

  Douglas F. Nixon, MD., Ph.D., Associate Professor of Medicine, University of California, San Francisco

Page:  1 2